Garrett M. Dancik

<i>TERT</i> promoter mutations and telomerase reactivation in urothelial cancer

Sumit Borah, Linghe Xi, Arthur J. Zaug et al. · Science · 2015 · 296 citations

Medicine, Genetics, Molecular Biology +17

Inhibition of the CCL2 receptor, CCR2, enhances tumor response to immune checkpoint therapy

Megan M. Tu, Hany Abdel-Hafiz, Robert T. Jones et al. · Communications Biology · 2020 · 172 citations · Full text

Life Sciences, Immunology, Oncology +17

A 20-gene model for molecular nodal staging of bladder cancer: development and prospective assessment

Steven C. Smith, Alexander S. Baras, Garrett M. Dancik et al. · The Lancet Oncology · 2011 · 148 citations · Full text

Medicine, Oncology, Urology +13

Concurrent Alterations in <i>TERT</i> , <i>KDM6A</i> , and the BRCA Pathway in Bladder Cancer

Michael L. Nickerson, Garrett M. Dancik, Kate M. Im et al. · Clinical Cancer Research · 2014 · 122 citations · Full text

Life Sciences, Genetics, Oncology +17

An Osteopontin/CD44 Axis in RhoGDI2-Mediated Metastasis Suppression

Mansoor Ahmed, Joseph L. Sottnik, Garrett M. Dancik et al. · Cancer Cell · 2016 · 80 citations · Full text

Medicine, Cancer Biology, Cell Biology +7